Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS).

被引：0

作者：

Martin Broto, Javier

Silva Moura, David

Ramos, Rafael

Braglia, Luca

Collini, Paola

Renne, Salvatore L.

Romagosa, Cleofe

Coindre, Jean Michel

Velasco, Valerie

Merlo, Domenico F.

Palmerini, Emanuela

Stacchiotti, Silvia

Quagliuolo, Vittorio

Lopez-Pousa, Antonio

Grignani, Giovanni

Blay, Jean-Yves

Brunello, Antonella

Picci, Piero

Casali, Paolo Giovanni

Gronchi, Alessandro

机构：

[1] Univ Seville, Virgen del Rocio Univ Hosp, Inst Biomed Res IBIS, CSIC, Seville, Spain

[2] Univ Seville, Inst Biomed Seville, Grp Adv Therapies & Biomarkers Sarcomas, Ibis,Hosp Univ Virgen Del Rocio,CSIC, Seville, Spain

[3] Hosp Univ Son Espases, Palma de Mallorca, Spain

[4] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Clin Trial Ctr, Genoa, Italy

[5] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Dept Epidemiol, Genoa, Italy

[6] Fdn IRCCS Ist Nazl Tumori, Dept Diagnost Pathol & Lab Med, Soft Tissue & Bone Pathol Histopathol & Pediat Pa, Milan, Italy

[7] Humanitas Res Hosp, Anat Pathol Unit, Milan, Italy

[8] H Vall dHebron, Barcelona, Spain

[9] Inst Bergonie, Bordeaux, France

[10] Inst Bergonie, Dept Pathol, Bordeaux, France

[11] IRCCS Ist Ortoped Rizzoli, Bologna, Italy

[12] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[13] Ist Clin Humanitas, Milan, Italy

[14] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[15] FPO IRCCS, Candiolo Canc Inst, Div Med Oncol, Candiolo, TO, Italy

[16] UNICANCER, Ctr Leon Berard, Lyon, France

[17] Ist Oncol Veneto IRCCS, Med Oncol Unit 1, Clin & Expt Oncol Dept, Padua, Italy

[18] Italian Sarcoma Grp, Bologna, Italy

[19] Fdn IRCCS Ist Nazl Tumori, Dept Canc Med, Adult Mesenchymal & Rare Tumor Unit, Milan, Italy

[20] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Sarcoma Serv, Milan, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

基金：

欧洲研究理事会;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1001

引用

页数：2

共 50 条

[31] Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Gronchi, Alessandro
Palmerini, Emanuela
Quagliuolo, Vittorio
Martin Broto, Javier
Lopez Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Tendero, Oscar
Diaz Beveridge, Robert
Ferraresi, Virginia
Lugowska, Iwona
Merlo, Domenico Franco
Fontana, Valeria
Marchesi, Emanuela
Braglia, Luca
Donati, Davide Maria
Palassini, Elena
Bianchi, Giuseppe
Marrari, Andrea
Morosi, Carlo
Stacchiotti, Silvia
Bague, Silvia
Coindre, Jean Michel
Dei Tos, Angelo Paolo
Picci, Piero
Bruzzi, Paolo
Casali, Paolo Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (19) : 2178 - +
[32] Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): Long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
Palassini, Elena
Ferrari, Stefano
Broto, Javier Martin
Verderio, Paolo
Lopez-Pousa, Antonio
Buonadonna, Angela
Miceli, Rosalba
Stacchiotti, Silvia
Dei Tos, Angelo Paolo
De Paoli, Antonino
Donati, Davide Maria
Poveda, Andres
Quagliuolo, Vittorio
Comandone, Alessandro
Bottelli, Stefano
Picci, Piero
Casali, Paolo Giovanni
Gronchi, Alessandro
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[33] Dissecting the role of tumor-infiltrating lymphocytes (TIL) in patients with high-risk soft-tissue sarcoma (STS) receiving neo-adjuvant chemotherapy (NAC) with regional hyperthermia (RHT)
Issels, R.
Bueclein, V.
Kampmann, E.
Knoesel, T.
Noessner, E.
Subklewe, M.
Lindner, L.
ANNALS OF ONCOLOGY, 2016, 27
[34] Full-dose neoadjuvant anthracycline plus ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized trial
Gronchi, A.
Ferrari, S.
Quagliuolo, V.
Martin Broto, J.
Lopez-Pousa, A.
Grignani, G.
Ferraresi, V.
Blay, J-Y.
Rutkowski, P.
Merlo, F. D.
Marchesi, E.
Ledesma, P.
Tos, A. P. Dei
Rosell, S. Bague
Coindre, J-M.
Morosi, C.
Stacchiotti, S.
Picci, P.
Bruzzi, P.
Casali, P. G.
ANNALS OF ONCOLOGY, 2016, 27
[35] Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults
Sparber-Sauer, Monika
Ferrari, Andrea
Kosztyla, Daniel
Ladenstein, Ruth
Cecchetto, Giovanni
Kazanowska, Bernarda
Scarzello, Giovanni
Ljungman, Gustaf
Milano, Giuseppe Maria
Niggli, Felix
Alaggio, Rita
Vokuhl, Christian
Casanova, Michela
Klingebiel, Thomas
Zin, Angelica
Koscielniak, Ewa
Bisogno, Gianni
PEDIATRIC BLOOD & CANCER, 2022, 69 (09)
[36] Impact of regional hyperthermia (RHT) on response to neo-adjuvant chemotherapy and survival of patients with high-risk soft-tissue sarcoma (HR-STS): Results of the randomized EORTC-ESHO intergroup trial (NCI-00003052)
Issels, R.
Lindner, L. H.
Wendtner, C. M.
Hohenberger, P.
Reichardt, P.
Daugaard, S.
Mansmann, U.
Hiddemann, W.
Blay, J. Y.
Verweij, J.
EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 2
[37] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).
Gronchi, Alessandro
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Lopez-Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Beveridge, Robert Diaz
Ferraresi, Virginia
Lugowska, Iwona
Pizzamiglio, Sara
Verderio, Paolo
Fontana, Valeria
Donati, Davide Maria
Palassini, Elena
Stacchiotti, Silvia
Miceli, Rosalba
Tos, Angelo Paolo Dei
Casali, Paolo Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[38] RESULTS OF HRQOL DATA FROM PALETTE: A RANDOMIZED DOUBLE BLIND PHASE III TRIAL OF PAZOPANIB VERSUS PLACEBO IN METASTATIC SOFT TISSUE SARCOMA (STS) PATIENTS. AN EORTC STBSG GLOBAL NETWORK STUDY (EORTC 62072)
Coens, C.
van der Graaf, W. T. A.
Blay, J.
Chawla, S. P.
Kim, D.
Sanfilippo, R.
Manson, S.
Ouali, M.
Marreaud, S.
Bottomley, A.
ANNALS OF ONCOLOGY, 2012, 23 : 483 - 483
[39] Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931
Kasper, Bernd
Ouali, Monia
van Glabbeke, Martine
Blay, Jean-Yves
Bramwell, Vivien H. C.
Woll, Penella J.
Hohenberger, Peter
Schoffski, Patrick
EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 449 - 456
[40] SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma.
Mowery, Yvonne Marie
Ballman, Karla V.
Riedel, Richard F.
Brigman, Brian E.
Attia, Steven
Meyer, Christian Frederick
Schuetze, Scott
Burgess, Melissa Amber
Chmielowski, Bartosz
Dickson, Mark Andrew
Hartner, Lee P.
Milhem, Mohammed M.
Tinoco, Gabriel
Van Tine, Brian Andrew
Wagner, Andrew J.
Reinke, Denise K.
Kirsch, David G.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

← 1 2 3 4 5 →